- Q4 2023 CorMedix Inc Earnings Call TranscriptMar 12, 2024$3.42 (-2.84%)Earnings
- Q3 2023 CorMedix Inc Earnings Call TranscriptNov 14, 2023$3.13 (+0.64%)Earnings
- CorMedix Inc at HC Wainwright Investment Conference - New York TranscriptSep 13, 2023
- Q2 2023 CorMedix Inc Earnings Call TranscriptAug 08, 2023$4.42 (+7.94%)Earnings
- CorMedix Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- CorMedix Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- CorMedix Inc at JMP Securities Life Sciences Conference TranscriptMay 16, 2023
- Q1 2023 CorMedix Inc Earnings Call TranscriptMay 15, 2023$5.15 (-0.58%)Earnings
- Q4 2022 CorMedix Inc Earnings Call TranscriptMar 30, 2023$4.14 (+13.11%)Earnings
- Q3 2022 CorMedix Inc Earnings Call TranscriptNov 10, 2022$3.09 (+9.19%)Earnings
- Q2 2022 CorMedix Inc Earnings Call TranscriptAug 11, 2022$3.72 (+10.06%)Earnings
- CorMedix Inc at JMP Securities Life Sciences Conference TranscriptJun 15, 2022
- Q1 2022 CorMedix Inc Earnings Call TranscriptMay 12, 2022$2.98 (-1.97%)Earnings
- Q4 2021 CorMedix Inc Earnings Call TranscriptMar 29, 2022$5.54 (-2.12%)Earnings
- CorMedix Inc Annual Shareholders Meeting TranscriptDec 09, 2021
- Q3 2021 CorMedix Inc Earnings Call TranscriptNov 09, 2021$5.23 (-1.13%)Earnings
- Q2 2021 CorMedix Inc Earnings Call TranscriptAug 12, 2021$5.95 (+0.68%)Earnings
- Q1 2021 CorMedix Inc Earnings Call TranscriptMay 13, 2021$7.56 (-3.94%)Earnings
- Q4 2020 CorMedix Inc Earnings Call TranscriptMar 30, 2021$8.99 (+3.45%)Earnings
- CorMedix Inc. - Special Call TranscriptMar 09, 2021
- CorMedix Inc Annual Shareholders Meeting TranscriptDec 16, 2020
- Q3 2020 CorMedix Inc Earnings Call TranscriptNov 05, 2020$5.38 (+1.89%)Earnings
- Q2 2020 CorMedix Inc Earnings Call TranscriptAug 10, 2020$4.25 (+3.16%)Earnings
- CorMedix Inc. - Special Call TranscriptMay 19, 2020
- Q1 2020 CorMedix Inc Earnings Call TranscriptMay 11, 2020$4.08 (+0.49%)Earnings
- Q4 2019 CorMedix Inc Earnings Call TranscriptMar 16, 2020$3.01 (-23.99%)Earnings
- Q3 2019 CorMedix Inc Earnings Call TranscriptNov 14, 2019$5.12 (-2.29%)Earnings
- Q2 2019 CorMedix Inc Earnings Call TranscriptAug 13, 2019$8.2 (-0.36%)Earnings
- Q1 2019 CorMedix Inc Earnings Call TranscriptMay 13, 2019Earnings
CorMedix Inc at HC Wainwright Investment Conference - New York Transcript
Good afternoon, everyone, and thank you for joining the 25 Annual H.C Wainwright Global Investment Conference. My name is Trevor levy, and I'm on the investment banking team at H.C. Wainwright. I would now like to introduce our next presenter. Please welcome Joe to discuss the CEO, and Matthew David, the CFO of CorMedix.
Thank you, Trevor, and thank you to the Wainwright team for having us here today to present the company. Just firstly refer to on page 2 here are forward-looking statements on this reflects some of the things we'll be talking about today.
So first, we start off with some background, who is CorMedix? CorMedix is a publicly listed small-cap pre-commercial stage biopharma company, developing therapeutic products for the prevention and treatment of life-threatening conditions and diseases.
A lead asset that we'll talk about today is DefenCath, novel, first-in-class non-antibiotic antimicrobial catheter lock solution designed to reduce
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)